Tg(SLC18A3-cre)Misa
Transgene Detail
|
Symbol: |
Tg(SLC18A3-cre)Misa |
Name: |
transgene insertion, Hidemi Misawa |
MGI ID: |
MGI:3793863 |
Synonyms: |
VAChT-cre |
Transgene: |
Tg(SLC18A3-cre)Misa Location: unknown
|
Alliance: |
Tg(SLC18A3-cre)Misa page
|
|
|
Transgene Type: |
|
Transgenic (Recombinase) |
Mutation: |
|
Insertion
|
|
|
Tg(SLC18A3-cre)Misa expression driven by
1 gene
Transgene expression driven by:
Organism |
Driver Gene |
Homolog in Mouse |
Note |
human |
SLC18A3 (6572) |
|
|
|
|
|
Mutation details: The transgenic construct consisted of an 11.3 kb fragment of the human cholinergic gene locus, containing the first 5 exons of CHAT and the first coding exon of SLC18A3 (located in intron 1 of CHAT). A cassette containing cre followed by IRES-EGFP was inserted at the start codon of the SLC18A3 gene. EGFP expression was undetected. The 11.3 kb fragment included various promoter elements including a distal enhancer, RE1/NRSE, and NGFRE. Founder mice contained approximately 50 copies. Expression of cre recombinase by the human SLC18A3 promoter began at postnatal day 7 and was restricted to a subset of cholinergic neurons in the somatomotor nuclei and medial habenular nucleus. Maximal levels of expression were reached around 8 months ofage, later onset than in the Tg(SLC18a3-cre)KMisa line. Transgenic expression was not observed in visceromotor or other central or peripheral cholinergic neurons.
(J:86160)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
SLC18A3
(human)
|
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:135268 Yamanaka K, et al., Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci. 2008 Mar;11(3):251-3 |
All: |
7 reference(s) |
|